The rapidly changing healthcare environment requires specialization at every level to take full advantage of market opportunities. 


Healthcare M&A update: Q2 2018

There were 230 reported healthcare M&A transactions that closed during the second quarter of 2018, with an aggregate reported deal value of $26.3 billion. Of these transactions, 42 were middle-market transactions with a reported aggregate deal value of $6.5 billion.

Learn more >

Healthcare and life sciences organizations face an increasingly competitive environment as they look to expand territory or consolidate operations.  Ongoing changes in the healthcare landscape influence the need to make critical business decisions.  Our team leverages deep industry relationships throughout the healthcare and life sciences sectors, to provide specialized advisory services for organizations and providers that identify opportunities and successfully conduct business transactions.   

Our industry specialists offer clients a wide-range of specific advisory services and proven transaction experience.  We work closely with healthcare systems, hospitals, managed care facilities, private practices, life sciences and biotechnology organizations with a unique perspective to transactions needed to grow or exit a business.  

For more information on this topic, or to learn how Baker Tilly Capital's healthcare and life sciences industries specialists can help, contact our team.

Baker Tilly Capital, LLC disclosure >
Baker Tilly Capital, LLC privacy policy >